NCT04420845

Brief Summary

This study will test whether adding sleep hygiene education and support to diabetes self-management education and support (DSMES) in diverse patients (African American, Hispanic, Pacific Islander, and Caucasian) with type 2 diabetes myelitis (T2DM) from rural UAMS Regional Programs clinics is more effective than DSMES alone. The specific aims for this study are:

  • Aim 1A (Primary): Determine if this model improves blood glucose levels as measured by the HbA1c test in diverse adults with T2DM.
  • Aim 1B: Determine the preliminary effectiveness of DSMES+SHES on sleep duration and sleep quality, blood pressure, fasting lipids, body mass index (BMI), self-management behavior, self-efficacy, diabetes-related distress, and diabetes-related quality of life in diverse adults with T2DM.
  • Aim 2A: Determine the feasibility and acceptability of DSMES+ SHES when implemented with diverse adults with T2DM.
  • Aim 2B: Determine the feasibility and acceptability of DSMES+ SHES implementation in Regional Programs clinics.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.8 years until next milestone

Study Start

First participant enrolled

March 25, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2022

Completed
Last Updated

September 3, 2024

Status Verified

April 1, 2022

Enrollment Period

Same day

First QC Date

May 28, 2020

Last Update Submit

August 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in mean HbA1c (NGSP%) from baseline to 12 weeks post-intervention

    A Siemens analyzer will be utilized to calculate HbA1c (%) for each participant at each time point. Changes in the primary outcome measure will be assessed from baseline to post-intervention.

    Baseline and 12 weeks post-intervention

Secondary Outcomes (12)

  • Change in sleep duration from baseline to 12 weeks post-intervention

    Baseline and 12 weeks post-intervention

  • Change in sleep quality from baseline to 12 weeks post-intervention

    Baseline and 12 weeks post-intervention

  • Change in mean blood pressure (systolic & diastolic, mmHg) from baseline to 12 weeks post-intervention

    Baseline and 12 weeks post-intervention

  • Change in mean body mass index (BMI) from baseline to 12 weeks post-intervention

    Baseline and 12 weeks post-intervention

  • Change in mean total cholesterol (mg/dL) from baseline to 12 weeks post-intervention

    Baseline and 12 weeks post-intervention

  • +7 more secondary outcomes

Study Arms (1)

Intervention

OTHER
Behavioral: Diabetes Self-Management and Support (DSMES) and Sleep Hygiene Education and Support (SHES)

Interventions

SHES outlines the importance of sleep for people with type 2 diabetes mellitus and provide practical information and guidance about sleep habits. Specifically, the focus will be on: avoiding consumption of caffeine, nicotine, alcohol; avoiding use of light emitting devices before bedtime; avoiding excessive intake of fluids or heavy meals before bedtime; promoting regulation of light, noise, and temperature in the bedroom; timing of and importance of exercise; maintaining consistent sleep and wake times; establishing a pre-bedtime routine; and managing stress.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Diagnosed with type 2 diabetes
  • Speak English

You may not qualify if:

  • Received DSME in the past three years
  • Have a condition that makes it unlikely they will be able to follow the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences Northwest

Fayetteville, Arkansas, 72703, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Sleep Hygiene

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 9, 2020

Study Start

March 25, 2022

Primary Completion

March 25, 2022

Study Completion

March 25, 2022

Last Updated

September 3, 2024

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations